• 1928 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

My research focuses on the identification of tumor specific mutant antigens recognized by the immune system as foreign that serve as the target of a T-cell response against tumors. We take advantage of cancer genomics and bioinformatics techniques to detect tumor-specific mutations that accumulate during transformation and use this information to predict which mutations are potentially antigenic.

Areas of Clinical Interest

Cancer/tumor immunotherapy

Fingerprint Dive into the research topics where Jeffrey Ward is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1928 Citations
  • 18 Article
  • 2 Comment/debate
  • 1 Conference contribution
  • 1 Review article

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

Ferris, S. T., Durai, V., Wu, R., Theisen, D. J., Ward, J. P., Bern, M. D., Davidson, J. T., Bagadia, P., Liu, T., Briseño, C. G., Li, L., Gillanders, W., Wu, G. F., Yokoyama, W. M., Murphy, T. L., Schreiber, R. D. & Murphy, K. M., Aug 27 2020, In : Nature. 584, 7822, p. 624-629 6 p.

Research output: Contribution to journalArticle

  • 2 Scopus citations

    Circulating tumor DNA profiling in small-cell lung cancer identifies potentially targetable alterations

    Devarakonda, S., Sankararaman, S., Herzog, B. H., Gold, K. A., Waqar, S. N., Ward, J. P., Raymond, V. M., Lanman, R. B., Chaudhuri, A. A., Owonikoko, T. K., Li, B. T., Poirier, J. T., Rudin, C. M., Govindan, R. & Morgensztern, D., Oct 15 2019, In : Clinical Cancer Research. 25, 20, p. 6119-6126 8 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    MHC-II neoantigens shape tumour immunity and response to immunotherapy

    Alspach, E., Lussier, D. M., Miceli, A. P., Kizhvatov, I., DuPage, M., Luoma, A. M., Meng, W., Lichti, C. F., Esaulova, E., Vomund, A. N., Runci, D., Ward, J. P., Gubin, M. M., Medrano, R. F. V., Arthur, C. D., White, J. M., Sheehan, K. C. F., Chen, A., Wucherpfennig, K. W., Jacks, T. & 3 others, Unanue, E. R., Artyomov, M. N. & Schreiber, R. D., Oct 31 2019, In : Nature. 574, 7780, p. 696-701 6 p.

    Research output: Contribution to journalArticle

  • 64 Scopus citations

    Erratum: High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy (Cell (2018) 175(4) (1014–1030.e19), (S009286741831242X) (10.1016/j.cell.2018.09.030))

    Gubin, M. M., Esaulova, E., Ward, J. P., Malkova, O. N., Runci, D., Wong, P., Noguchi, T., Arthur, C. D., Meng, W., Alspach, E., Medrano, R. F. V., Fronick, C., Fehlings, M., Newell, E. W., Fulton, R., Sheehan, K., Oh, S., Schreiber, R. & Artomov, M., Nov 15 2018, In : Cell. 175, 5, p. 1443 1 p.

    Research output: Contribution to journalComment/debate

  • 11 Scopus citations

    Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)

    Fehlings, M., Simoni, Y., Penny, H. L., Becht, E., Loh, C. Y., Gubin, M. M., Ward, J. P., Wong, S. C., Schreiber, R. D. & Newell, E. W., Dec 1 2018, In : Nature communications. 9, 1, 3000.

    Research output: Contribution to journalComment/debate

    Open Access